Shanghai Fosun Pharmaceutical (Group) Market Cap

Shanghai Fosun Pharmaceutical (Group) has a market cap or net worth of 61.73 billion as of January 3, 2025. Its market cap has decreased by -14.37% in one year.

Market Cap

61.73B

Enterprise Value

94.71B

Revenue

46.09B

Ranking

n/a

PE Ratio

26.36

Stock Price

13.68

Market Cap Chart

Since August 9, 2005, Shanghai Fosun Pharmaceutical (Group)'s market cap has increased from 4.19B to 61.73B, an increase of 1,371.55%. That is a compound annual growth rate of 14.85%.

Market Cap History

Date	Market Cap	% Change
Jan 3, 2025	61.73B	-2.93%
Dec 31, 2024	63.59B	-6.28%
Dec 29, 2023	67.85B	-30.95%
Dec 30, 2022	98.27B	-29.69%
Dec 31, 2021	139.76B	-6.44%
Dec 31, 2020	149.39B	105.18%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	152.35B
Hansoh Pharmaceutical Group Company	98.87B
JD Health International	84.92B
WuXi Biologics	68.94B
Sinopharm Group	64.91B
Innovent Biologics	58.07B
Sino Biopharmaceutical	56.25B
CSPC Pharmaceutical Group	53.23B

Market Cap Rankings